Stenting of the Patent Ductus Arteriosus

Katherine Price1, Justin R Ryan2, Howaida El-Said3

  • 1Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnett Avenue, Cincinnati, OH, USA.

Insights

PDA stenting has evolved significantly, offering improved outcomes for infants with duct-dependent pulmonary circulation. This technique is also used for pulmonary arterial hypertension and hybrid procedures, with ongoing advancements.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Interventional Cardiology

Background:

  • Patent ductus arteriosus (PDA) stenting has evolved since the 1990s.
  • Technical advancements have led to improved outcomes.
  • Some centers now exclusively use PDA stenting for duct-dependent pulmonary circulation.

Purpose of the Study:

  • Review indications and outcomes for PDA stenting.
  • Describe the PDA stenting procedure.
  • Discuss future directions in PDA stenting.

Main Methods:

  • Review of existing literature and clinical data on PDA stenting.
  • Description of the technical aspects of the PDA stenting procedure.
  • Analysis of outcomes in various patient populations.

Main Results:

  • PDA stenting has demonstrated improved outcomes in infants with duct-dependent pulmonary circulation.
  • The procedure has been adapted for palliative treatment of suprasystemic pulmonary arterial hypertension.
  • PDA stenting is a component of the hybrid procedure.

Conclusions:

  • PDA stenting is a valuable intervention with expanding applications.
  • Continued technical advancements are expected to further enhance outcomes.
  • Future research should focus on long-term results and novel applications.